The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.
Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.
In the report, one unit refers to one bottle.
Pfizer, Mylan and Novartis are the leaders of the Latanoprost industry, which take about 57% market share. North America is the major region of the global market, which takes about 35% market share.
The global Latanoprost market was valued at US$ 1344.6 million in 2020 and is expected to reach US$ 1565.8 million by the end of 2027, growing at a CAGR of 2.2% during 2021-2027.
This report focuses on Latanoprost volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Latanoprost market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Latanoprost Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Brand Drug
Generic Drug
Segment by Application
Open-angle Glaucoma
Close-angle Glaucoma
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Pfizer
Mylan
Novartis
Apotex
Teva
Taj Pharma
CR Zizhu
Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.
Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.
In the report, one unit refers to one bottle.
Pfizer, Mylan and Novartis are the leaders of the Latanoprost industry, which take about 57% market share. North America is the major region of the global market, which takes about 35% market share.
The global Latanoprost market was valued at US$ 1344.6 million in 2020 and is expected to reach US$ 1565.8 million by the end of 2027, growing at a CAGR of 2.2% during 2021-2027.
This report focuses on Latanoprost volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Latanoprost market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Latanoprost Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Brand Drug
Generic Drug
Segment by Application
Open-angle Glaucoma
Close-angle Glaucoma
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Pfizer
Mylan
Novartis
Apotex
Teva
Taj Pharma
CR Zizhu
Index1 Latanoprost Market Overview
1.1 Product Overview and Scope of Latanoprost
1.2 Latanoprost Segment by Type
1.2.1 Global Latanoprost Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Brand Drug
1.2.3 Generic Drug
1.3 Latanoprost Segment by Application
1.3.1 Global Latanoprost Sales Comparison by Application: (2021-2027)
1.3.2 Open-angle Glaucoma
1.3.3 Close-angle Glaucoma
1.4 Global Latanoprost Market Size Estimates and Forecasts
1.4.1 Global Latanoprost Revenue 2016-2027
1.4.2 Global Latanoprost Sales 2016-2027
1.4.3 Latanoprost Market Size by Region: 2016 Versus 2021 Versus 2027
2 Latanoprost Market Competition by Manufacturers
2.1 Global Latanoprost Sales Market Share by Manufacturers (2016-2021)
2.2 Global Latanoprost Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Latanoprost Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Latanoprost Manufacturing Sites, Area Served, Product Type
2.5 Latanoprost Market Competitive Situation and Trends
2.5.1 Latanoprost Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Latanoprost Players Market Share by Revenue
2.5.3 Global Latanoprost Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Latanoprost Retrospective Market Scenario by Region
3.1 Global Latanoprost Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Latanoprost Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Latanoprost Market Facts & Figures by Country
3.3.1 North America Latanoprost Sales by Country
3.3.2 North America Latanoprost Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Latanoprost Market Facts & Figures by Country
3.4.1 Europe Latanoprost Sales by Country
3.4.2 Europe Latanoprost Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Latanoprost Market Facts & Figures by Region
3.5.1 Asia Pacific Latanoprost Sales by Region
3.5.2 Asia Pacific Latanoprost Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Latanoprost Market Facts & Figures by Country
3.6.1 Latin America Latanoprost Sales by Country
3.6.2 Latin America Latanoprost Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Latanoprost Market Facts & Figures by Country
3.7.1 Middle East and Africa Latanoprost Sales by Country
3.7.2 Middle East and Africa Latanoprost Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Latanoprost Historic Market Analysis by Type
4.1 Global Latanoprost Sales Market Share by Type (2016-2021)
4.2 Global Latanoprost Revenue Market Share by Type (2016-2021)
4.3 Global Latanoprost Price by Type (2016-2021)
5 Global Latanoprost Historic Market Analysis by Application
5.1 Global Latanoprost Sales Market Share by Application (2016-2021)
5.2 Global Latanoprost Revenue Market Share by Application (2016-2021)
5.3 Global Latanoprost Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Latanoprost Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Pfizer Latanoprost Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Latanoprost Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Mylan Latanoprost Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Latanoprost Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Novartis Latanoprost Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Corporation Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Latanoprost Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Apotex Latanoprost Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Teva
6.5.1 Teva Corporation Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Latanoprost Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Teva Latanoprost Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Taj Pharma
6.6.1 Taj Pharma Corporation Information
6.6.2 Taj Pharma Description and Business Overview
6.6.3 Taj Pharma Latanoprost Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Taj Pharma Latanoprost Product Portfolio
6.6.5 Taj Pharma Recent Developments/Updates
6.7 CR Zizhu
6.6.1 CR Zizhu Corporation Information
6.6.2 CR Zizhu Description and Business Overview
6.6.3 CR Zizhu Latanoprost Sales, Revenue and Gross Margin (2016-2021)
6.4.4 CR Zizhu Latanoprost Product Portfolio
6.7.5 CR Zizhu Recent Developments/Updates
7 Latanoprost Manufacturing Cost Analysis
7.1 Latanoprost Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Latanoprost
7.4 Latanoprost Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Latanoprost Distributors List
8.3 Latanoprost Customers
9 Latanoprost Market Dynamics
9.1 Latanoprost Industry Trends
9.2 Latanoprost Growth Drivers
9.3 Latanoprost Market Challenges
9.4 Latanoprost Market Restraints
10 Global Market Forecast
10.1 Latanoprost Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Latanoprost by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Latanoprost by Type (2022-2027)
10.2 Latanoprost Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Latanoprost by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Latanoprost by Application (2022-2027)
10.3 Latanoprost Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Latanoprost by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Latanoprost by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Latanoprost Sales (M Unit) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Latanoprost Sales (M Unit) Comparison by Application (2021-2027)
Table 3. Global Latanoprost Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Latanoprost Covered in This Study
Table 5. Global Latanoprost Sales (M Unit) of Key Manufacturers (2016-2021)
Table 6. Global Latanoprost Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Latanoprost Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Latanoprost Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Latanoprost Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Latanoprost Manufacturing Sites and Area Served
Table 11. Manufacturers Latanoprost Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Latanoprost by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Latanoprost as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Latanoprost Sales by Region (2016-2021) & (M Unit)
Table 16. Global Latanoprost Sales Market Share by Region (2016-2021)
Table 17. Global Latanoprost Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Latanoprost Sales by Country (2016-2021) & (M Unit)
Table 19. North America Latanoprost Sales Market Share by Country (2016-2021)
Table 20. North America Latanoprost Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Latanoprost Revenue Market Share by Country (2016-2021)
Table 22. Europe Latanoprost Sales by Country (2016-2021) & (M Unit)
Table 23. Europe Latanoprost Sales Market Share by Country (2016-2021)
Table 24. Europe Latanoprost Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Latanoprost Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Latanoprost Sales by Region (2016-2021) & (M Unit)
Table 27. Asia Pacific Latanoprost Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Latanoprost Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Latanoprost Revenue Market Share by Region (2016-2021)
Table 30. Latin America Latanoprost Sales by Country (2016-2021) & (M Unit)
Table 31. Latin America Latanoprost Sales Market Share by Country (2016-2021)
Table 32. Latin America Latanoprost Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Latanoprost Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Latanoprost Sales by Country (2016-2021) & (M Unit)
Table 35. Middle East and Africa Latanoprost Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Latanoprost Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Latanoprost Revenue Market Share by Country (2016-2021)
Table 38. Global Latanoprost Sales (M Unit) by Type (2016-2021)
Table 39. Global Latanoprost Sales Market Share by Type (2016-2021)
Table 40. Global Latanoprost Revenue (Million US$) by Type (2016-2021)
Table 41. Global Latanoprost Revenue Share by Type (2016-2021)
Table 42. Global Latanoprost Price (USD/Unit) by Type (2016-2021)
Table 43. Global Latanoprost Sales (M Unit) by Application (2016-2021)
Table 44. Global Latanoprost Sales Market Share by Application (2016-2021)
Table 45. Global Latanoprost Revenue (Million US$) by Application (2016-2021)
Table 46. Global Latanoprost Revenue Share by Application (2016-2021)
Table 47. Global Latanoprost Price (USD/Unit) by Application (2016-2021)
Table 48. Pfizer Corporation Information
Table 49. Pfizer Description and Business Overview
Table 50. Pfizer Latanoprost Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Pfizer Latanoprost Product
Table 52. Pfizer Recent Developments/Updates
Table 53. Mylan Corporation Information
Table 54. Mylan Description and Business Overview
Table 55. Mylan Latanoprost Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Mylan Latanoprost Product
Table 57. Mylan Recent Developments/Updates
Table 58. Novartis Corporation Information
Table 59. Novartis Description and Business Overview
Table 60. Novartis Latanoprost Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Novartis Latanoprost Product
Table 62. Novartis Recent Developments/Updates
Table 63. Apotex Corporation Information
Table 64. Apotex Description and Business Overview
Table 65. Apotex Latanoprost Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Apotex Latanoprost Product
Table 67. Apotex Recent Developments/Updates
Table 68. Teva Corporation Information
Table 69. Teva Description and Business Overview
Table 70. Teva Latanoprost Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Teva Latanoprost Product
Table 72. Teva Recent Developments/Updates
Table 73. Taj Pharma Corporation Information
Table 74. Taj Pharma Description and Business Overview
Table 75. Taj Pharma Latanoprost Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Taj Pharma Latanoprost Product
Table 77. Taj Pharma Recent Developments/Updates
Table 78. CR Zizhu Corporation Information
Table 79. CR Zizhu Description and Business Overview
Table 80. CR Zizhu Latanoprost Sales (M Unit), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. CR Zizhu Latanoprost Product
Table 82. CR Zizhu Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Latanoprost Distributors List
Table 86. Latanoprost Customers List
Table 87. Latanoprost Market Trends
Table 88. Latanoprost Growth Drivers
Table 89. Latanoprost Market Challenges
Table 90. Latanoprost Market Restraints
Table 91. Global Latanoprost Sales Forecast by Type (2022-2027) & (M Unit)
Table 92. Global Latanoprost Sales Market Share Forecast by Type (2022-2027)
Table 93. Global Latanoprost Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 94. Global Latanoprost Revenue Market Share Forecast by Type (2022-2027)
Table 95. Global Latanoprost Sales Forecast by Application (2022-2027) & (M Unit)
Table 96. Global Latanoprost Sales Market Share Forecast by Application (2022-2027)
Table 97. Global Latanoprost Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 98. Global Latanoprost Revenue Market Share Forecast by Application (2022-2027)
Table 99. Global Latanoprost Sales Forecast by Region (2022-2027) & (M Unit)
Table 100. Global Latanoprost Sales Market Share Forecast by Region (2022-2027)
Table 101. Global Latanoprost Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 102. Global Latanoprost Revenue Market Share Forecast by Region (2022-2027)
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Latanoprost
Figure 2. Global Latanoprost Market Share by Type in 2020 & 2027
Figure 3. Brand Drug Product Picture
Figure 4. Generic Drug Product Picture
Figure 5. Global Latanoprost Market Share by Application in 2020 & 2027
Figure 6. Open-angle Glaucoma
Figure 7. Close-angle Glaucoma
Figure 8. Global Latanoprost Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Latanoprost Market Size 2016-2027 (US$ Million)
Figure 10. Global Latanoprost Sales 2016-2027 (M Unit)
Figure 11. Global Latanoprost Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Latanoprost Sales Share by Manufacturers in 2020
Figure 13. Global Latanoprost Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Latanoprost Players: Market Share by Revenue in 2020
Figure 15. Latanoprost Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Latanoprost Sales Market Share by Region (2016-2021)
Figure 17. Global Latanoprost Sales Market Share by Region in 2020
Figure 18. Global Latanoprost Revenue Market Share by Region (2016-2021)
Figure 19. Global Latanoprost Revenue Market Share by Region in 2020
Figure 20. U.S. Latanoprost Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Latanoprost Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Latanoprost Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Latanoprost Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Latanoprost Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Latanoprost Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Latanoprost Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Latanoprost Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Latanoprost Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Latanoprost Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Latanoprost Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Latanoprost Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Latanoprost Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Latanoprost Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Latanoprost Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Latanoprost Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Latanoprost Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Latanoprost Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Latanoprost Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Latanoprost Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Latanoprost Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Latanoprost Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Latanoprost Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. U.A.E Latanoprost Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Latanoprost by Type (2016-2021)
Figure 45. Sales Market Share of Latanoprost by Application (2016-2021)
Figure 46. Sales Market Share of Latanoprost by Application in 2020
Figure 47. Revenue Share of Latanoprost by Application (2016-2021)
Figure 48. Revenue Share of Latanoprost by Application in 2020
Figure 49. Manufacturing Cost Structure of Latanoprost
Figure 50. Manufacturing Process Analysis of Latanoprost
Figure 51. Latanoprost Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
